Clinical trial

Could Single-anastomosis Gastric Bypass Be a Curative Treatment for Type II Diabetes?

NCT03412253

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Study at a glance

Registry-backed

Could Single-anastomosis Gastric Bypass Be a Curative Treatment for Type II Diabetes?

Design: INTERVENTIONAL · Status: SUSPENDED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov
StatusSUSPENDED
Study typeINTERVENTIONAL
Start date2013-11-01
PhaseNA
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.